Bahi-an, Jeffrey T.
HRN: 05-16-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2022
CEFTRIAXONE 1G (VIAL)
09/26/2022
10/02/2022
IV
2 Grams
Q 24 Hrs
Cap- Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes